CR Medical (01515): Fang Xin Joins Board as Non-Executive Director, Replacing Retiring Ge Lu

Bulletin Express
03/11

China Resources Medical Holdings Company Limited (CR Medical, 01515) announced that, effective 11 March 2026, Ms. Ge Lu has retired as a non-executive director and member of the Remuneration Committee, and Mr. Fang Xin has been appointed to both positions.

Ms. Ge confirmed no disagreement with the board and no matters requiring shareholder or Hong Kong Stock Exchange attention. The board formally thanked her for her contributions.

Mr. Fang, aged 50, is currently a director of China Resources Healthcare Group Limited and an external director at China Resources (Holdings) Company Limited business units. His past roles include: • Non-executive director, China Resources Vanguard (Holding) Company Limited (since February 2025) • Non-executive director, China Resources Gas Group Limited (1193 HK) (since January 2025) • General manager, China Resources Chemical Innovative Materials Co., Ltd. (301090 SZ), January 2022 – December 2024

Fang joined China Resources Group in August 1996 and has held multiple senior positions across its chemical businesses. He holds a bachelor’s degree in engineering from Beijing Institute of Technology.

The new director has signed a three-year service agreement running from 11 March 2026 to 10 March 2029. He will receive no remuneration for his non-executive role and is subject to retirement by rotation and re-election at the company’s annual general meeting.

As of the announcement date, Fang holds indirect interests in approximately 101,265 shares of China Resources Chemical Innovative Materials Co., Ltd. and 20,000 shares of China Resources Power Holdings Company Limited (0836 HK). He has no other interests in CR Medical or its associated corporations under Hong Kong’s Securities and Futures Ordinance and reports no additional directorships or relationships requiring disclosure under the Listing Rules.

Following the change, CR Medical’s board comprises four executive directors (Yu Hai, Zhang Chuang, Wang Yuexing, Wu Xinchun), one non-executive director (Fang Xin) and four independent non-executive directors (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze).

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10